Atrial Fibrillation News and Research

RSS
Atrial fibrillation (AF) is the most common arrhythmia. An arrhythmia is a problem with the speed or rhythm of the heartbeat. A disorder in the heart’s electrical system causes AF and other types of arrhythmia. AF occurs when rapid, disorganized electrical signals in the heart’s two upper chambers, called the atria, cause them to contract very fast and irregularly (this is called fibrillation). As a result, blood pools in the atria and isn’t pumped completely into the heart’s two lower chambers, called the ventricles. When this happens, the heart’s upper and lower chambers don’t work together as they should. Often, people who have AF may not even feel symptoms. However, even when not noticed, AF can lead to an increased risk of stroke. In many patients, particularly when the rhythm is extremely rapid, AF can cause chest pain, heart attack, or heart failure. AF may occur rarely or every now and then, or it may become a persistent or permanent heart rhythm lasting for years.
Adherence to guideline-related therapies can reduce heart failure patients' mortality rate

Adherence to guideline-related therapies can reduce heart failure patients' mortality rate

FDA approves St. Jude Medical's Safire BLU and Therapy Cool Path irrigated ablation catheters

FDA approves St. Jude Medical's Safire BLU and Therapy Cool Path irrigated ablation catheters

Positive top-line data from Inhibitex INX-189 Phase 1b trial against HCV

Positive top-line data from Inhibitex INX-189 Phase 1b trial against HCV

Electrophysiologists use new robotic system to treat cardiac arrhythmias

Electrophysiologists use new robotic system to treat cardiac arrhythmias

Study links specific cardiovascular risk factors to AF episodes

Study links specific cardiovascular risk factors to AF episodes

Medtronic's Resolute drug-eluting stent pivotal U.S. data to be presented at ACC.11

Medtronic's Resolute drug-eluting stent pivotal U.S. data to be presented at ACC.11

Merck to return rights for betrixaban to Portola

Merck to return rights for betrixaban to Portola

Dabigatran etexilate is less costly, more effective for stroke treatment in patients with AF

Dabigatran etexilate is less costly, more effective for stroke treatment in patients with AF

FDA approves Medtronic's Consulta and Syncra pacemaker systems

FDA approves Medtronic's Consulta and Syncra pacemaker systems

Cancer patients with spinal fractures can benefit from Kyphon Balloon Kyphoplasty

Cancer patients with spinal fractures can benefit from Kyphon Balloon Kyphoplasty

Dabigatran etexilate cost-effective compared to current care for stroke prevention in AF patients

Dabigatran etexilate cost-effective compared to current care for stroke prevention in AF patients

Actress invites public to vote for projects that increase AF-related stroke awareness

Actress invites public to vote for projects that increase AF-related stroke awareness

SLEH treats irregular heartbeat with novel minimally invasive cold cryoballoon technology

SLEH treats irregular heartbeat with novel minimally invasive cold cryoballoon technology

CardioFocus secures $5M in debt financing from Silicon Valley Bank

CardioFocus secures $5M in debt financing from Silicon Valley Bank

Celera reports net revenue of $34.9 million for fourth quarter of 2010

Celera reports net revenue of $34.9 million for fourth quarter of 2010

ACT initiates enrollment in TEMPASURE cardiac ablation catheter CE Mark clinical trial

ACT initiates enrollment in TEMPASURE cardiac ablation catheter CE Mark clinical trial

Human growth, height, size: Reasons to be small

Human growth, height, size: Reasons to be small

Pico-Tesla receives ISO certification for Resonator device

Pico-Tesla receives ISO certification for Resonator device

First U.S. catheter ablation procedure for treatment of AF performed at Mount Sinai

First U.S. catheter ablation procedure for treatment of AF performed at Mount Sinai

BIOTRONIK's new ablation catheter is now available in Europe

BIOTRONIK's new ablation catheter is now available in Europe

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.